PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20043943-6 2010 Present study is an attempt to investigate the possible role of COX inhibitors (selective COX-2 inhibitor and preferential COX-2 inhibitors) against quinolinic acid-induced behavioral, oxidative stress and mitochondrial enzyme complex alterations in rats. Quinolinic Acid 149-164 cytochrome c oxidase II, mitochondrial Rattus norvegicus 90-95 21237233-3 2011 Therefore, the present study has been designed to explore the neuroprotective potential of licofelone (dual COX-2/5-LOX inhibitor) against quinolinic acid induced Huntington like symptom in rats. Quinolinic Acid 139-154 cytochrome c oxidase II, mitochondrial Rattus norvegicus 108-113 21362433-9 2011 Chronic treatment with the selective COX-2 inhibitors significantly restored the mitochondrial enzyme complex activities as well as attenuated TNF-alpha, IL-6 and caspase-3 levels as compared to the quinolinic acid treated group. Quinolinic Acid 199-214 cytochrome c oxidase II, mitochondrial Rattus norvegicus 37-42 20043943-6 2010 Present study is an attempt to investigate the possible role of COX inhibitors (selective COX-2 inhibitor and preferential COX-2 inhibitors) against quinolinic acid-induced behavioral, oxidative stress and mitochondrial enzyme complex alterations in rats. Quinolinic Acid 149-164 cytochrome c oxidase II, mitochondrial Rattus norvegicus 123-128 19927170-4 2009 The present study aims to elucidate the effects of caffeic acid (a specific inhibitor for LOX), rofecoxib (a specific inhibitor for COX-2), and their combination in ameliorating QA-induced neurotoxicity in rats. Quinolinic Acid 178-180 cytochrome c oxidase II, mitochondrial Rattus norvegicus 132-137